Pharma & Biotech

Eli Lilly finds itself navigating contrasting fortunes as the pharmaceutical giant simultaneously celebrates a major regulatory victory while confronting an...

Viking Therapeutics finds itself at a critical investment crossroads, pulled in opposite directions by two powerful market forces. Soaring takeover...

Assembly Biosciences shares extended their decline for a third consecutive session, closing Thursday's trading at $24.67 after shedding 3.37% of...

aTyr Pharma's stock faced another challenging session on Friday, declining nearly 6% to close at $0.841 per share. The biotech...

The biotechnology landscape is undergoing significant transformation, and BioNTech appears strategically positioned for this new era. As major pharmaceutical companies...

The recent trading activity for India Globalization Capital (IGC Pharma) presents a classic case of biotech volatility. Despite announcing significant...

Celularity Inc. witnessed a dramatic trading session on Friday, with its stock price climbing 10.29% to close at $2.25. This...

A significant corporate transformation has been finalized, marking a new chapter for the former bluebird bio. The company now operates...

Investors in Ocugen experienced a day of conflicting signals this Friday. The biotech firm's stock declined by more than 4%,...

Eli Lilly, the pharmaceutical giant, has unsettled investors with a surprising move: the sudden termination of a mid-stage clinical trial...